[4] [6] Understanding how tirzepatide works is essential when considering discontinuation, as its effects on glucose metabolism, gastric motility, and appetite regulation do not persist indefinitely after stopping treatment
Importantly, these medications are not approved for type 1 diabetes
A primary concern for individuals starting the Obesema 0.25mg Injection is whether the introduction of a peptide will trigger severe stomach upset. From a clinical perspective, this lowest 0.25mg strength is explicitly designed to prevent that issue. By introducing the medicine at a very minimal baseline volume, your body builds tolerance smoothly. To support this process, focus on eating smaller portions and staying well-hydrated during your first few weeks
You can change this day as long as it has been three days since the last injection
Subcutaneous injections were used to administer all therapy doses once a day
The tablets are available in three dosage strengths